• Paul McCormick was named executive chairman of Cardiogenesis (Irvine, California). McCormick was named chairman of the board in 2007. He is the former CEO of Endologix. Cardiogenesis specializes in therapies for the treatment of chronic cardiac ischemia.

• Richard Davis has been named to the board of NMT Medical (Boston). Davis is the company's COO. NMT Medical makes implant technologies for interventional cardiologists to treat heart disease.

• Jason Hein has been promoted to senior VP, sales, marketing and product development for both the Vascular Intervention and Lead Management businesses of Spectranetics (Colorado Springs, Colorado). Hein has been with Spectranetics since July 2006.